Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The CLAHRC funded ‘Depression in Cancer’ project addresses this ‘translational gap’; taking the findings from clinical trials and working out how best to implement them in the real-world setting of the NHS – the first step towards wider roll out across the NHS and maximising patient benefit.

This solution developed by CLAHRC researchers, with external funding from Cancer Research UK, comprises a screening system, for identifying symptoms of depression in cancer patients, and the DCPC treatment approach itself. It is being implemented and evaluated in the Oxford Cancer Centre[1].

Additionally, the implementation of this system allows us to ask patients about other cancer symptoms before their oncology appointments, ensuring that their needs are addressed and that consultations are both focused and efficient.

A steering committee including patients and carers was also set up to help guide the implementation.